Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 May 26;14(11):2221.
doi: 10.3390/nu14112221.

Effects of Omega-3 Supplementation Alone and Combined with Resistance Exercise on Skeletal Muscle in Older Adults: A Systematic Review and Meta-Analysis

Stephen M Cornish  1   2   3 , Dean M Cordingley  3   4 , Keely A Shaw  5 , Scott C Forbes  2   6 , Taylor Leonhardt  5 , Ainsley Bristol  5 , Darren G Candow  7 , Philip D Chilibeck  5
Affiliations
Meta-Analysis

Effects of Omega-3 Supplementation Alone and Combined with Resistance Exercise on Skeletal Muscle in Older Adults: A Systematic Review and Meta-Analysis

Stephen M Cornish et al. Nutrients. .

Abstract

Sarcopenia negatively affects skeletal muscle mass and function in older adults. Omega-3 (ω-3) fatty acid supplementation, with or without resistance exercise training (RET), is suggested to play a role as a therapeutic component to prevent or treat the negative effects of sarcopenia. A systematic review and meta-analysis were conducted on the impact of ω-3 fatty acid supplementation with or without RET on measures of muscle mass and function in older adults (≥55 y). The data sources included SPORTDiscus, PubMed, and Medline. All the study types involving ω-3 fatty acid supplementation on measures of muscle mass and function in older adults (without disease) were included. The mean differences (MDs) or standardized mean differences (SMDs) with 95% confidence intervals were calculated and pooled effects assessed. Sixteen studies (1660 females, 778 males) met our inclusion criteria and were included in the meta-analysis. ω-3 fatty acid supplementation did not impact lean tissue mass (SMD 0.09 [-0.10, 0.28]). Benefits were observed for lower body strength (SMD 0.54 [0.33, 0.75]), timed-up-and-go (MD 0.29 [0.23, 0.35]s), and 30-s sit-to-stand performance (MD 1.93 [1.59, 2.26] repetitions) but not walking performance (SMD -0.01 [-0.10, 0.07]) or upper body strength (SMD 0.05 [-0.04, 0.13]). Supplementing with ω-3 fatty acids may improve the lower-body strength and functionality in older adults.

Keywords: PUFA; anabolism; elderly; inflammation; sarcopenia; strength.

PubMed Disclaimer

Conflict of interest statement

D.M.C. is affiliated with the Pan Am Clinic Foundation which receives general education and research support from ConMed Linvatec, Ossur, Zimmer Biomet, and Arthrex.

Figures

Figure 1
Figure 1
PRISMA diagram: flow chart of study selection process.
Figure 2
Figure 2
Pooled analysis of the impact of omega-3 supplementation on lean body mass with and without resistance training [27,29,31,34,35,37,39,40].
Figure 3
Figure 3
Pooled analysis of the impact of omega-3 supplementation on lower body strength with and without resistance training [27,31,33,35,36,37,40,42].
Figure 4
Figure 4
Pooled analysis of the impact of omega-3 supplementation with and without resistance training on upper body strength [27,28,29,30,31,33,34,36,37,39,40,41].
Figure 5
Figure 5
Pooled analysis of the impact of omega-3 supplementation on timed-up-and-go test. Note that all mean results entered for each study are reduction in seconds within groups [28,34,36,37,39,42].
Figure 6
Figure 6
Pooled analysis of the impact of omega-3 supplementation on sit-to-stand performance.
Figure 7
Figure 7
Pooled analysis of the impact of omega-3 supplementation on walking speed.
See this image and copyright information in PMC

References

    1. Cruz-Jentoft A.J., Sayer A.A. Sarcopenia. Lancet. 2019;393:2636–2646. doi: 10.1016/S0140-6736(19)31138-9. - DOI - PubMed
    1. Beaudart C., Zaaria M., Pasleau F., Reginster J.-Y., Bruyère O. Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS ONE. 2017;12:e0169548. doi: 10.1371/journal.pone.0169548. - DOI - PMC - PubMed
    1. Bruyère O., Beaudart C., Ethgen O., Reginster J.-Y., Locquet M. The Health Economics Burden of Sarcopenia: A Systematic Review. Maturitas. 2019;119:61–69. doi: 10.1016/j.maturitas.2018.11.003. - DOI - PubMed
    1. Lee D.-Y., Shin S. Sarcopenia Is Associated with Metabolic Syndrome in Korean Adults Aged over 50 Years: A Cross-Sectional Study. Int. J. Environ. Res. Public Health. 2022;19:1330. doi: 10.3390/ijerph19031330. - DOI - PMC - PubMed
    1. Buchmann N., Fielitz J., Spira D., König M., Norman K., Pawelec G., Goldeck D., Demuth I., Steinhagen-Thiessen E. Muscle Mass and Inflammation in Older Adults: Impact of the Metabolic Syndrome. Gerontology. 2022:1–10. doi: 10.1159/000520096. - DOI - PMC - PubMed

Substances